ICU Medical, Inc. (NASDAQ:ICUI) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) have received an average recommendation of "Moderate Buy" from the five brokerages that are presently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $173.00.

A number of equities analysts recently commented on ICUI shares. Jefferies Financial Group started coverage on ICU Medical in a report on Monday, October 14th. They issued a "hold" rating and a $183.00 price objective on the stock. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. Raymond James raised their target price on shares of ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research note on Thursday, September 12th. KeyCorp raised their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a report on Wednesday, November 13th. Finally, StockNews.com downgraded shares of ICU Medical from a "buy" rating to a "hold" rating in a report on Tuesday, November 12th.

ICU Medical Stock Up 1.3 %

Shares of ICUI traded up $2.12 during trading hours on Monday, reaching $169.98. The company's stock had a trading volume of 235,850 shares, compared to its average volume of 275,376. The firm has a market cap of $4.16 billion, a price-to-earnings ratio of -36.73 and a beta of 0.66. ICU Medical has a 1-year low of $82.82 and a 1-year high of $196.26. The company has a quick ratio of 1.08, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The company has a 50 day moving average of $176.43 and a two-hundred day moving average of $143.31.

Insider Activity at ICU Medical

In other ICU Medical news, VP Daniel Woolson sold 2,502 shares of the company's stock in a transaction on Friday, August 30th. The stock was sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the sale, the vice president now owns 13,107 shares in the company, valued at $2,139,324.54. This represents a 16.03 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Vivek Jain sold 12,000 shares of the stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total value of $2,141,520.00. Following the sale, the chief executive officer now owns 104,593 shares of the company's stock, valued at approximately $18,665,666.78. This represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 38,502 shares of company stock valued at $6,573,496 in the last 90 days. Corporate insiders own 6.70% of the company's stock.

Hedge Funds Weigh In On ICU Medical

Institutional investors have recently modified their holdings of the business. Innealta Capital LLC purchased a new stake in ICU Medical in the second quarter valued at $32,000. Hexagon Capital Partners LLC lifted its stake in shares of ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier's stock valued at $36,000 after buying an additional 122 shares during the period. Allworth Financial LP raised its stake in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier's stock worth $36,000 after purchasing an additional 100 shares during the period. EntryPoint Capital LLC increased its position in shares of ICU Medical by 731.5% in the first quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier's stock worth $48,000 after acquiring an additional 395 shares in the last quarter. Finally, Russell Investments Group Ltd. grew its holdings in ICU Medical by 46.4% during the 1st quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier's stock valued at $59,000 after purchasing an additional 173 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.